Date clarification: PEG’s 2026Q2 earnings event is today, Tuesday, August 4, 2026—not tomorrow. This preview reflects information available before the report.
PSEG enters Q2 with a strong first-quarter beat, reaffirmed full-year guidance, and a constructive multi-year regulated-investment story. The central question for this report is less about a single quarter’s EPS—Q2 is seasonally a lower earnings period—and more about whether management can reaffirm confidence in the $4.28–$4.40 operating-EPS range while showing that its utility capital plan, nuclear fleet economics, and balance sheet remain on track.
The setup appears balanced:
PSEG reported Q1 2026 operating EPS of $1.55, up from $1.43 in Q1 2025, and maintained full-year 2026 operating-EPS guidance of $4.28–$4.40.
At the $4.34 midpoint, Q1 represented about 36% of the full-year plan. That is a solid start, but management explicitly characterized the annual earnings pattern as more weighted to winter and summer conditions. The key result from Q2 is therefore likely to be the quality of the full-year reaffirmation, rather than simply the year-over-year EPS comparison.
For context, in Q2 2025, PSEG earned:
| Metric | Q2 2025 |
|---|---|
| GAAP EPS | $1.17 |
| Operating EPS | $0.77 |
| PSE&G operating earnings | $332M |
| PSEG Power & Other operating earnings | $52M |
| Nuclear generation | 7.5 TWh |
The low reported operating contribution from Power in Q2 2025 illustrates why headline quarterly EPS can be volatile and why investors should focus on the utility/PSEG Power bridge and the full-year outlook.
The regulated utility is the core of PEG’s investment case. PSE&G delivered $577 million of operating earnings in Q1, up $31 million year over year, driven primarily by distribution margin, transmission investment, energy-efficiency investment, gas-system modernization, and customer growth.
For 2026, PSEG plans approximately $4.2 billion of regulated capital spending. Its 2026–2030 plan calls for:
Q2 should provide a useful check on execution: whether spend remains on budget, whether the newly commenced $1.4 billion GSMP III program is progressing as planned, and whether customer/load growth continues to support the investment outlook.
What would be positive: reaffirmation of the $4.2B CapEx plan, no cost or permitting issues, and evidence that transmission, electrification, and energy-efficiency investments continue to translate into margin growth.
What would concern investors: any indication that New Jersey affordability pressure could delay projects, lower returns, constrain the capital plan, or change the utility-business model in a way that weakens rate-base compounding.
PSEG Power has become a more important source of upside as nuclear economics improve. The company’s Q1 Power & Other operating earnings increased to $201 million, despite the absence of the prior zero-emission-credit program, as higher gas-operations and capacity revenue and lower O&M offset lower generation volume.
For Q2, investors should watch nuclear output closely:
The comparison is nuanced. Q2 2025 nuclear generation was strong at 7.5 TWh, helped by the absence of a Hope Creek refueling outage that had affected the prior-year period. This year’s Salem Unit 2 outage could make generation a more visible issue, even if the full-year plan remains intact.
What would be positive: outage execution in line with schedule and budget, maintained 30–32 TWh annual output guidance, and stable commentary on realized pricing, hedges, and nuclear O&M.
What would concern investors: an extended outage, a cut to annual generation expectations, higher outage costs, or weaker-than-expected Power economics after accounting for the loss of ZEC revenue.
PSEG’s Q1 result was strong, but management did not raise its $4.28–$4.40 range. At the time, management suggested that getting through the summer would provide more visibility on the full year.
That makes a guidance reaffirmation the most likely constructive outcome for Q2. A raise would be a stronger signal, but investors should not assume it: PSEG has higher interest and depreciation costs embedded in its outlook, and nuclear outage execution plus summer operating conditions can still influence results.
The 2026 outlook is underpinned by:
Read-through: Maintaining the range with a confident message on the back-half setup should be adequate. Narrowing to the upper half or raising guidance would likely require clear evidence that nuclear, utility O&M, and financing costs are all tracking favorably.
PSEG’s core plan does not require speculative outcomes. But the stock’s long-term upside increasingly depends on what happens around PJM resource adequacy, large load growth, transmission, and potential nuclear contracting.
The major topics to listen for are:
PEG closed at $76.64 on August 3, down approximately:
The recent weakness suggests the market is looking for confirmation that the company’s regulated-growth narrative remains intact amid rising financing costs, policy uncertainty, and broader concerns about utility affordability. A routine quarterly beat without stronger commentary on guidance, capital execution, or nuclear economics may therefore produce a muted reaction.
Conversely, a reaffirmation paired with clean nuclear outage execution, disciplined financing commentary, and visible regulatory progress could support a more favorable response.
Constructive, but focused on execution rather than a dramatic earnings catalyst. PSEG offers a relatively defensive regulated-utility foundation supplemented by improving nuclear capacity and energy economics. The immediate report should validate whether management can convert a strong Q1 into continued full-year confidence despite a nuclear outage quarter and heightened regulatory attention.
The best outcome is straightforward: guidance maintained or improved, utility CapEx reaffirmed, Salem Unit 2 outage progressing cleanly, and no deterioration in the company’s regulatory or financing outlook. The principal downside risk is not necessarily a weak quarter in isolation; it is any signal that affordability-driven regulation, outage execution, or higher capital costs could compromise the company’s 6%–8% long-term operating-EPS growth framework.